Tritace Protect expanding presence in cardiovascular market

Published: 2007-03-20 06:56:00

Updated: 2007-03-20 06:56:00

Handok Pharm said on March 16 that its Tritace Protect (ramipril) 10mg tablet has been expanding their presence in the domestic cardiovascular market since its launching on March of Last year.

Tritace Protect has been successfully landed on 130 general hospitals across the country, exceeding 2...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK